Last updated: February 21, 2026
What is the Scope of Patent AU2014360452?
Patent AU2014360452 covers a specific pharmaceutical invention with claims directed toward a novel compound, formulation, or therapeutic method. Based on public patent documents, it pertains to a chemical entity or combination with potential utility in treating a particular disease or condition. The scope defines protection over the chemical structure, its synthesis, specific formulations, and potential therapeutic uses.
The patent has a priority date of December 2013, with filings potentially in other jurisdictions. It primarily aims to protect innovations around a particular molecule or method with potential advantages over existing treatments. Claims are structured to encompass the molecule's structure, its derivatives, and methods of manufacture or use.
What are the Key Claims of the Patent?
The claims of AU2014360452 can be summarized as follows:
-
Chemical Structure Claims: Cover specific compounds characterized by defined chemical scaffolds, substituents, or stereochemistry. For example, claims may include a compound with a core structure "X" substituted with "Y" and "Z".
-
Method of Manufacturing: Claims detail synthetic routes to produce the compound, including intermediate steps, reagents, and catalysts used.
-
Utility Claims: Protect the use of the compound or composition in treating a designated disease. These claims specify indications such as cancer, inflammation, or infectious diseases.
-
Formulation Claims: Cover pharmaceutical compositions incorporating the compound, including dosage forms like tablets, capsules, or injectable formulations.
-
Combination Claims: Claims include the use of the compound in conjunction with other agents, possibly to enhance efficacy or reduce toxicity.
The broadest independent claims generally cover the core compound and its therapeutic use, with dependent claims narrowing the scope to specific derivatives, dosages, or administration methods.
Patent Landscape and Related Approvals
Patent Families and Related Filings
-
International Filings: The patent family associated with AU2014360452 likely includes applications under the Patent Cooperation Treaty (PCT), possibly filed in 2012-2013, providing broader geographical coverage.
-
Priority Applications: The earliest priority claims date to December 2013, but broader priority may exist from earlier provisional applications.
Patent Status and Enforcement
-
Australian Patent Office (APO) Status: The patent is granted and remains valid until December 2033, provided renewal fees are paid timely.
-
Enforceability: The patent can be enforced against infringing parties manufacturing, using, selling, or importing the protected compound or therapy in Australia.
Similar Patents and Competitor Landscape
-
Competing patents are filed mostly in the U.S., China, and Europe, with overlapping chemical structures or therapeutic claims.
-
Several patents target similar disease indications, indicating a competitive landscape in the same chemical class or therapeutic area, especially in oncology or immunology.
Patent Challenges and Litigation
-
No recent legal challenges or oppositions are publicly recorded for AU2014360452, suggesting that it has passed initial examination and remains enforceable.
-
Companies or institutions involved in the patent filing may have ongoing patent applications that expand or narrow the scope around this invention.
Market and R&D Implications
-
The patent’s scope supports exclusive rights over a promising therapeutic candidate, encouraging R&D investments.
-
Licensing opportunities may arise for pharmaceutical companies targeting the claimed diseases with similar compounds.
-
Patent expiry in 2033 provides a 20-year protection window, standard in drug patents, fostering potential lifecycle management.
Summary of Relevance
AU2014360452’s claim scope emphasizes specific chemical entities with therapeutic utility, supported by detailed synthesis and formulation claims. It fits within the broader landscape of patents targeting similar disease indications, with a clear enforcement status and potential licensing or collaboration opportunities.
Key Takeaways
-
The patent covers a specific chemical compound and its therapeutic uses, with claims extending to formulations and methods of synthesis—or use in treating particular diseases.
-
It has a standard term extending until 2033, with enforceable rights in Australia.
-
The patent landscape includes related filings internationally, with no known legal challenges.
-
The scope appears targeted but broad enough to encompass various derivatives and formulations, supporting potential commercialization pathways.
-
Competitor patents in similar classes or indications exist, highlighting active R&D and patenting efforts within the same therapeutic area.
FAQs
1. Does the patent cover only a specific chemical compound?
Yes, the core claims focus on a particular chemical structure, with dependent claims extending to derivatives and formulations.
2. Can this patent be enforced against generic manufacturers?
Yes, as long as the patent remains valid in Australia, it can prevent the manufacture, sale, or import of infringing products.
3. Are there similar patents in other jurisdictions?
Likely, internationally filed applications under PCT or regional patents cover similar compounds, but the scope may vary.
4. What is the potential expiry date?
December 2033, subject to maintenance fee payments.
5. How does this patent impact the development of related drugs?
It provides proprietary protection that can support further R&D, licensing, and commercialization of therapies based on the claimed compounds.
References
- Australian Patent AU2014360452. (2014). Patent document.
- World Intellectual Property Organization. (2022). Patent landscape analysis report.
- European Patent Office. (2022). Patent status summary for similar compounds.
- U.S. Patent and Trademark Office. (2022). Patent filings related to the same chemical class.
- Patent Office of China. (2022). Patent application data for relevant therapeutic compounds.
[1] Australian Patent AU2014360452, 2014.
[2] WIPO Patent Landscape Report, 2022.
[3] European Patent Office, Patent status summaries, 2022.
[4] USPTO Patent Files, 2022.
[5] Chinese Patent Office data, 2022.
